Get the Stockscreener App
229.35
0.58%
1.32
After Hours:
229.35
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $229.35, with a volume of 1.11M.
It is up +0.58% in the last 24 hours and down -3.60% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$228.03
Open:
$227.78
24h Volume:
1.11M
Relative Volume:
0.47
Market Cap:
$53.72B
Revenue:
$250.74B
Net Income/Loss:
$1.55B
P/E Ratio:
35.07
EPS:
6.5398
Net Cash Flow:
$4.39B
1W Performance:
+1.59%
1M Performance:
-3.60%
6M Performance:
+7.15%
1Y Performance:
+45.95%
1-Day Range:
$227.03
$230.61
1-Week Range:
$220.37
$230.61
52-Week Range:
$137.75
$243.21
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
229.35 | 53.41B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
850.06 | 98.45B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
311.15 | 60.29B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
84.61 | 9.74B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.46 | 1.29B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
4 Medical Stocks With the Right Setup for Q2 Earnings Beats - TradingView
The Buyback Machine Hiding Behind Cardinal Health’s Thin Margins - Trefis
Cardinal Health Inc (CAH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
How Cardinal Health Inc. (CAH) Affects Rotational Strategy Timing - Stock Traders Daily
Cardinal Health stock trades steady as investors weigh recent earnings and segment trends - Ad-hoc-news.de
CAH|Cardinal Health Inc|Price:228.030|Chg%:+2.010 - TradingKey
Cardinal Health Inc (CAH) Institutional Confidence - TradingKey
Cardinal Health Inc (CAH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ohio’s Cardinal Health company acquires two medical supply companies for $360 million - NBC4 WCMH-TV
Do Cardinal Health’s New Home-Health Deals Reshape the Bull Case for CAH? - Yahoo Finance
Cardinal Health stock trades steadily as recent earnings and guidance frame investor expectations - AD HOC NEWS
Cardinal Health, Inc. Stock 12‑Month Price Target Raised to $255.6, Implies 16% Upside - TradingView
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health (CAH) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Mizuho Securities Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $240 - Moomoo
Citigroup Adjusts Price Target on Cardinal Health to $265 From $245, Maintains Buy Rating - Moomoo
Here's What to Expect From Cardinal Health's Next Earnings Report - inkl
Cardinal Health stock trades steady as investors weigh recent earnings and healthcare distribution m - AD HOC NEWS
Cardinal Health (CAH) Is Buying Strive Medical And AdaptHealth Diabetes Business - Sahm
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Deals tracker: Cross Country Healthcare acquired by Knox Lane - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Neogen (NEOG) and Cardinal Health (CAH) - The Globe and Mail
Cardinal Health Expands Home Care Business With Two Acquisitions - Zacks Investment Research
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH) and Neogen (NEOG) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Cardinal Health (CAH) and Neogen (NEOG) - The Globe and Mail
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardinal Health (CAH) and Neogen (NEOG) - The Globe and Mail
Baird Adjusts Price Target on Cardinal Health to $251 From $248, Maintains Outperform Rating - Moomoo
Cardinal Health puts $360 million toward two acquisitions that expand home care business - DOTmed
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health stock trades steadily as investors weigh recent earnings and dividend support - AD HOC NEWS
Cardinal Health Expands Home Care Business With Two Strategic Acquisitions - HLTH
Cardinal Health acquires two home-care businesses for $360M - The Business Journals
Cardinal Health stock trades steady as recent earnings highlight margin focus - AD HOC NEWS
Cardinal Health (CAH) Stock Draws Fresh Price Target Split After Analyst Revisions - Yahoo Finance UK
Cardinal Health Expands Home Care Business with $360M Acquisition Pair - Modern Distribution Management
Cardinal Health stock trades steady as recent quarterly earnings highlight margin pressures and dive - AD HOC NEWS
AdaptHealth to sell business unit to Cardinal Health for $235M - The Business Journals
Cardinal Health makes acquisition duo worth $360m for home care business advance - Yahoo Finance
Cardinal inks 2 acquisitions in bid to expand at-home services - Healthcare Dive
CARDINAL HEALTH, INC : UBS RAISES TARGET PRICE TO $274 FROM $260 - webull.com
Cardinal Health to Acquire 2 Firms to Boost at-Home Solutions - Medical Product Outsourcing
Cardinal Health expands home care business with two tuck-in acquisitions - Morningstar
Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million - 101 WIXX
AdaptHealth sells diabetes unit to Cardinal Health for $235M By Investing.com - Investing.com Nigeria
Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore
Cardinal Health (CAH) Expands Portfolio with Strategic Acquisiti - GuruFocus
Cardinal Health to Buy AdaptHealth Diabetes Business, Strive Medical for $360 Million - Moomoo
Cardinal Health Acquires Two Medical Companies to Boost Home Solutions - Intellectia AI
Cardinal Health Agrees to Buy Strive Medical, AdaptHealth's Mail-Order Diabetes Business For $360M - Moomoo
AdaptHealth sells diabetes unit to Cardinal Health for $235M - Investing.com
Cardinal Health to acquire two home care businesses for $360M - Investing.com Canada
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):